Zealand Pharma files New Drug Application with U.S. FDA for dasiglucagon HypoPal® rescue pen, secures DKK 137 million in additional investment, and accelerates readiness of U.S. commercial operations: Interim report for Q1 2020

https://www.globenewswire.com/news-release/2020/05/14/2033549/0/en/Zealand-Pharma-files-New-Drug-Application-with-U-S-FDA-for-dasiglucagon-HypoPal-rescue-pen-secures-DKK-137-million-in-additional-investment-and-accelerates-readiness-of-U-S-commerc.html

press release